(Q37414139)

20 August 2017

title

Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary (English)

1 reference

20 August 2017

0 references

2

K Kian Ang

1 reference

20 August 2017

Jean-Louis Lefebvre

1

1 reference

20 August 2017

Larynx Preservation Consensus Panel

series ordinal

3

1 reference

20 August 2017

publication date

1 April 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

31

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

429-441

1 reference

The prognostic significance of tracheostomy in carcinoma of the larynx treated with radiotherapy and surgery for salvage

20 August 2017

cites work

1 reference

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

21 January 2018

1 reference

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

7 January 2021

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

7 January 2021

Head and neck cancer: changing epidemiology, diagnosis, and treatment

1 reference

7 January 2021

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

7 January 2021

Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm

1 reference

7 January 2021

Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.

1 reference

7 January 2021

Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group

1 reference

7 January 2021

Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.

1 reference

7 January 2021

Randomized trial of induction chemotherapy in larynx carcinoma

1 reference

7 January 2021

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

1 reference

7 January 2021

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

1 reference

7 January 2021

Cervical lymph node metastatic patterns of squamous carcinomas in the upper aerodigestive tract

1 reference

7 January 2021

Stage T3 squamous cell carcinoma of the glottic larynx: A comparison of laryngectomy and irradiation

1 reference

7 January 2021

Epilarynx: pharynx or larynx?

1 reference

7 January 2021

Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer

1 reference

7 January 2021

Development and validation of the voice handicap index-10.

1 reference

7 January 2021

Validation of an instrument to measure voice-related quality of life (V-RQOL).

1 reference

7 January 2021

Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer

1 reference

7 January 2021

Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients

1 reference

7 January 2021

Changes in quality of life over 1 year in patients with head and neck cancer

1 reference

7 January 2021

Clinical predictors of quality of life in patients with head and neck cancer.

1 reference

7 January 2021

Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

1 reference

7 January 2021

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

7 January 2021

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

1 reference

7 January 2021

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

7 January 2021

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

1 reference

7 January 2021

A penetration-aspiration scale

1 reference

7 January 2021

Oropharyngeal swallow efficiency as a representative measure of swallowing function

1 reference

7 January 2021

A performance status scale for head and neck cancer patients.

1 reference

7 January 2021

Reliability of clinician-based (GRBAS and CAPE-V) and patient-based (V-RQOL and IPVI) documentation of voice disorders.

1 reference

7 January 2021

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.

1 reference

7 January 2021

Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.

1 reference

7 January 2021

Quality of life assessment in laryngectomized individuals: do we need additions to standard questionnaires in specific clinical research projects?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21081

1 reference

20 August 2017

1 reference